MBX MBX Biosciences
- 24.000
- +0.450+1.91%
MBX Biosciences News
MBX Bio Drops Despite Bullish Views on Street
MBX Biosciences Price Target Announced at $35.00/Share by Jefferies
Express News | Mbx Biosciences Shares Down 5.1%; Brokerages Initiate Coverage With Bullish Ratings
MBX Biosciences Earns Buy Rating at Three Investment Firms
A Quick Look at Today's Ratings for MBX Biosciences(MBX.US), With a Forecast Between $30 to $44
MBX Biosciences Analyst Ratings
Analysts Offer Insights on Healthcare Companies: MBX Biosciences, Inc. (MBX) and Zenas BioPharma, Inc. (ZBIO)
Buy Rating Affirmed on MBX Biosciences, Inc. Based on Promising Therapeutic Pipeline and Market Potential
MBX Biosciences Initiated With a Buy at Guggenheim
Express News | Mbx Biosciences Inc : JP Morgan Initiates Coverage With Overweight Rating; Target Price $30
Express News | Mbx Biosciences Presents Mbx 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the Asbmr 2024 Annual Meeting
MBX Biosciences Presents MBX 2109 Phase 2 Avail Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting
Biotech IPOs Return as Sector Recovers After Funding Overhang
Express News | Deep Track Capital, LP Reports 9.48% Passive Stake in Mbx Biosciences as of Sept 13- SEC Filing
Tuesday's Insider Trades: Major Buys at MBX Biosciences, Sells at Palantir
OrbiMed Advisors LLC Acquires New Stake in MBX Biosciences Inc
NEA 17 LP Buys $8 Million in MBX Biosciences Shares
MBX Biosciences Director Buys $10 Million in IPO Shares
MBX Biosciences Director Buys $12 Million in Company Stock
MBX Biosciences Director Buys $12m in Company Stock
Analysis
Price Target
No Data
No Data
